Related Experiment Video
Updated: May 23, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferons as biomarkers and effectors: lessons learned from animal models
Cassandra M Berry1, Paul J Hertzog, Niamh E Mangan
1Centre for Innate Immunity & Infectious Diseases, Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia. c.berry@murdoch.edu.au
Interferons (IFNs) and their stimulated genes (ISGs) can serve as biomarkers for disease outcomes in infectious and inflammatory conditions. Animal models reveal how IFN responses inform disease pathogenesis and therapeutic development.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Interferons (IFNs) are crucial cytokines with diverse biological effects mediated by Interferon-Stimulated Genes (ISGs).
- IFN and ISG profiles offer potential as biomarkers for disease prognosis in various conditions.
- Animal models are instrumental in dissecting IFN response mechanisms and disease pathogenesis.
Purpose of the Study:
- To provide an overview of Interferon (IFN) roles in viral infections and autoimmune diseases.
- To highlight the utility of Interferon-Stimulated Genes (ISGs) as potential disease biomarkers.
- To discuss insights gained from animal models regarding IFN system parameters and their clinical relevance.
Main Methods:
- Review of scientific literature on Interferons (IFNs) and Interferon-Stimulated Genes (ISGs).
- Analysis of data from animal models of viral infections and autoimmune diseases.
- Examination of the role of gene knockout models in understanding IFN responses.
Main Results:
- IFN and ISG sets can establish distinct immunological signatures for different diseases.
- Animal models demonstrate cause-and-effect relationships in the IFN response pathway.
- IFN system parameters identified in animal models correlate with disease outcomes.
Conclusions:
- Interferons (IFNs) and their ISG products are valuable biomarkers for predicting disease outcomes.
- Insights from animal models guide the development of targeted therapies and vaccines.
- Understanding IFN responses is critical for advancing clinical research and therapeutic strategies.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
10:10Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016